Literature DB >> 17501721

NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation.

Lena Serrander1, Laetitia Cartier, Karen Bedard, Botond Banfi, Bernard Lardy, Olivier Plastre, Andrzej Sienkiewicz, Lászlo Fórró, Werner Schlegel, Karl-Heinz Krause.   

Abstract

NOX4 is an enigmatic member of the NOX (NADPH oxidase) family of ROS (reactive oxygen species)-generating NADPH oxidases. NOX4 has a wide tissue distribution, but the physiological function and activation mechanisms are largely unknown, and its pharmacology is poorly understood. We have generated cell lines expressing NOX4 upon tetracycline induction. Tetracycline induced a rapid increase in NOX4 mRNA (1 h) followed closely (2 h) by a release of ROS. Upon tetracycline withdrawal, NOX4 mRNA levels and ROS release decreased rapidly (<24 h). In membrane preparations, NOX4 activity was selective for NADPH over NADH and did not require the addition of cytosol. The pharmacological profile of NOX4 was distinct from other NOX isoforms: DPI (diphenyleneiodonium chloride) and thioridazine inhibited the enzyme efficiently, whereas apocynin and gliotoxin did not (IC(50)>100 muM). The pattern of NOX4-dependent ROS generation was unique: (i) ROS release upon NOX4 induction was spontaneous without need for a stimulus, and (ii) the type of ROS released from NOX4-expressing cells was H(2)O(2), whereas superoxide (O(2)(-)) was almost undetectable. Probes that allow detection of intracellular O(2)(-) generation yielded differential results: DHE (dihydroethidium) fluorescence and ACP (1-acetoxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine) ESR measurements did not detect any NOX4 signal, whereas a robust signal was observed with NBT. Thus NOX4 probably generates O(2)(-) within an intracellular compartment that is accessible to NBT (Nitro Blue Tetrazolium), but not to DHE or ACP. In conclusion, NOX4 has a distinct pharmacology and pattern of ROS generation. The close correlation between NOX4 mRNA and ROS generation might hint towards a function as an inducible NOX isoform.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501721      PMCID: PMC1948990          DOI: 10.1042/BJ20061903

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Authors:  Taishan Hu; Satish P Ramachandrarao; Senthuran Siva; Cathryn Valancius; Yanqing Zhu; Kalyankar Mahadev; Irene Toh; Barry J Goldstein; Marilyn Woolkalis; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.

Authors:  Junya Kuroda; Kazunori Nakagawa; Tomoko Yamasaki; Kei-ichiro Nakamura; Ryu Takeya; Futoshi Kuribayashi; Shinobu Imajoh-Ohmi; Kazuhiko Igarashi; Yosaburo Shibata; Katsuo Sueishi; Hideki Sumimoto
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

3.  NOX4 as an oxygen sensor to regulate TASK-1 activity.

Authors:  Young-Mee Lee; Byung-Joo Kim; Yang-Sook Chun; Insuk So; Hyunsung Choi; Myung-Suk Kim; Jong-Wan Park
Journal:  Cell Signal       Date:  2005-07-14       Impact factor: 4.315

4.  NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.

Authors:  Ioan Cucoranu; Roza Clempus; Anna Dikalova; Patrick J Phelan; Srividya Ariyan; Sergey Dikalov; Dan Sorescu
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

5.  Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.

Authors:  Yves Gorin; Karen Block; James Hernandez; Basant Bhandari; Brent Wagner; Jeffrey L Barnes; Hanna E Abboud
Journal:  J Biol Chem       Date:  2005-08-31       Impact factor: 5.157

Review 6.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Authors:  Michael V Berridge; Patries M Herst; An S Tan
Journal:  Biotechnol Annu Rev       Date:  2005

7.  Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases.

Authors:  Kendra D Martyn; Linda M Frederick; Katharina von Loehneysen; Mary C Dinauer; Ulla G Knaus
Journal:  Cell Signal       Date:  2005-05-31       Impact factor: 4.315

8.  Expression and localization of NOX2 and NOX4 in primary human endothelial cells.

Authors:  J D Van Buul; M Fernandez-Borja; E C Anthony; P L Hordijk
Journal:  Antioxid Redox Signal       Date:  2005 Mar-Apr       Impact factor: 8.401

9.  Role of NAD(P)H oxidase in the regulation of cardiac L-type Ca2+ channel function during acute hypoxia.

Authors:  Livia C Hool; Carla A Di Maria; Helena M Viola; Peter G Arthur
Journal:  Cardiovasc Res       Date:  2005-09-01       Impact factor: 10.787

10.  Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma.

Authors:  Jodi K Maranchie; Ye Zhan
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

View more
  275 in total

1.  NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

Authors:  Min Zhang; Alison C Brewer; Katrin Schröder; Celio X C Santos; David J Grieve; Minshu Wang; Narayana Anilkumar; Bin Yu; Xuebin Dong; Simon J Walker; Ralf P Brandes; Ajay M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

3.  ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

Authors:  Natalie Sampson; Rafal Koziel; Christoph Zenzmaier; Lukas Bubendorf; Eugen Plas; Pidder Jansen-Dürr; Peter Berger
Journal:  Mol Endocrinol       Date:  2011-01-27

4.  NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

Authors:  Abel Martin-Garrido; David I Brown; Alicia N Lyle; Anna Dikalova; Bonnie Seidel-Rogol; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

5.  Increased NADPH oxidase-derived superoxide is involved in the neuronal cell death induced by hypoxia-ischemia in neonatal hippocampal slice cultures.

Authors:  Qing Lu; Mark S Wainwright; Valerie A Harris; Saurabh Aggarwal; Yali Hou; Thomas Rau; David J Poulsen; Stephen M Black
Journal:  Free Radic Biol Med       Date:  2012-06-19       Impact factor: 7.376

6.  Role of Nox2 in diabetic kidney disease.

Authors:  Young-Hyun You; Shinichi Okada; San Ly; Karin Jandeleit-Dahm; David Barit; Tamehachi Namikoshi; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

7.  Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.

Authors:  Anu Shah; Ling Xia; Howard Goldberg; Ken W Lee; Susan E Quaggin; I George Fantus
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

8.  Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4.

Authors:  Giovanna Frazziano; Imad Al Ghouleh; Jeff Baust; Sruti Shiva; Hunter C Champion; Patrick J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

9.  Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

Authors:  J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

Review 10.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.